NSW Branch | Toxicology: sodium channel blockers and lithium toxicity

7:00pm Wednesday, 23 September 2020
8:00pm Wednesday, 23 September 2020

This presentation will provide an overview of sodium channel blockers and lithium-induced toxicity. The focus is to understand treatment options in patients with sodium channel blocker poisoning and lithium toxicity and examine the evidence behind these.  

Learning Objectives: 

  • Identify presentations of sodium channel blocker poisoning and lithium toxicity
  • Describe the mechanism and effect of these presentations
  • Identify diagnostic methods for sodium channel blocker poisoning and lithium toxicity
  • Outline treatment options and the evidence-base for these presentations

This webinar will commence at 7:00pm AEST

Registration rates:

Member: Free
Non-member: $50

  • Register in the purple box below, then click on 'cart' at the top of the page (or under your menu options) and continue through checkout.
  • Still having trouble registering? Follow our handy ‘how to’ guide
  • Click here to view our Terms and Conditions


* You will receive a confirmation email upon completion of your registration. If you do not receive this within 4 hours, you have not completed your registration and your space is not guaranteed. Please contact the secretariat by emailing events@shpa.org.au.

$50.00 *
$50.00 *
* Price includes GST where applicable

Contact Information

Additional Information


  • A/Prof Betty Chan, Head of Clinical Toxicology Unit & Clinical Toxicologist, Prince of Wales Hospital; Emergency Physician, Prince of Wales Hospital; VMO Toxicologist, The Children’s Hospital at Westmead & NSW Poisons Information Centre; Conjoint Associate Professor, University of New South Wales

Competency Standards:

  • Standard 3.1.2 Assess medication management practices and needs
  • Standard 3.3.1 Undertake a clinical review
  • Standard 3.5.2 Promote evidence-based medicine use

National Competency Standards Framework for Pharmacists in Australia, 2016


This activity has been accredited for 1 hour of Group-1 CPD (or 1 CPD credit), suitable for inclusion in an individual pharmacist’s CPD plan. The accreditation number is S2020/39.